The DOI matches its Crossref record; 98 of the 98 references it cites were found in a registry or an index; 9 of the 48 sources its claims cite were checked for support.
Structural Evolution and Dynamics of the p53 Proteins
Open accessAbstract
The family of the p53 tumor suppressive transcription factors includes p73 and p63 in addition to p53 itself. Given the high degree of amino-acid-sequence homology and structural organization shared by the p53 family members, they display some common features (i.e., induction of cell death, cell-cycle arrest, senescence, and metabolic regulation in response to cellular stress) as well as several distinct properties. Here, we describe the structural evolution of the family members with recent advances on the molecular dynamic studies of p53 itself. A crucial role of the carboxy-terminal domain in regulating the properties of the DNA-binding domain (DBD) supports an induced-fit mechanism, in which the binding of p53 on individual promoters is preferentially regulated by the K(OFF) over K(ON).
Overview
CoChat Summary
TL;DR
This review describes the structural organization and evolution of the p53 family and uses molecular dynamics to argue that the intrinsically disordered carboxy-terminal domain regulates DNA-binding domain function through an induced-fit mechanism. It proposes that promoter selectivity depends more on \(K_{\text{OFF}}\) than \(K_{\text{ON}}\) and traces p53-family functions from germ-cell quality control to stem-cell maintenance and tumor suppression.
Key findings
- The p53 family includes p53, p63, and p73, which share domain organization and high amino-acid-sequence homology, especially in the DNA-binding domain (DBD); p63 and p73 are evolutionarily older. In human cancers, 90% of oncogenic p53 mutations lie in the DBD, and p53 binds DNA as a homotetramer with up to 100-fold higher affinity than the single monomer.
- Molecular dynamics of the p53 tetramer-DNA complex shows long-range communication between the carboxy-terminal/oligomerization regions and the DBD, with nonsymmetrical dynamics of loop L1 across the four monomers. The carboxy-terminal domain can induce conformational changes in the DBD, supporting an induced-fit model in which promoter binding selectivity is preferentially regulated by \(K_{\text{OFF}}\) rather than \(K_{\text{ON}}\).
- In the evolutionary model, the ancestral p53-family function was germ-cell quality control. TAp63α is stored as an inactive dimer; DNA-damage phosphorylation via ATM, c-Abl, and Chk2 activates an open tetramer with 20-fold higher DNA-binding affinity, inducing PUMA and NOXA and oocyte death. p73 contributes to blastocyst development and spermatogenesis, while p53 regulates implantation through LIF.
- Full-length p53 MD indicates that the oligomerization domain is fully structured only in the tetrameric form, whereas DBD secondary structure is already formed in the isolated monomer. For mutant R175H, maintaining native Zn binding increases DBD flexibility, while an alternative Zn-binding site reduces carboxy-terminal flexibility.
Methods
- Design: narrative review integrating published structural biology—NMR, electron microscopy, small-angle X-ray scattering, FRET, and crystallography—with molecular dynamics simulations of p53.
- Data/sample: human p53 (393 residues; TAD, PRR, DBD, OD, CTD), p63/p73 isoforms, and cancer-related mutant R175H; MD systems included full-length p53 monomer and p53 tetramer bound to DNA.
- Main analysis: comparison of secondary-structure content over simulation time, per-residue root-mean-square fluctuation over 200 nsec, essential dynamics/eigenvectors, and dynamic cross-correlation maps to infer interdomain motions and induced-fit behavior.
Limitations
- The paper has no dedicated limitations section. It states that intrinsically disordered regions hamper crystallization and that most structural studies have addressed only single domains or fractions; it also states that a full Cryo-EM structure of the p53-DNA complex would provide a more solid base for realistic MD analysis.
- Evident from the text: this is a review synthesizing prior work and the authors’ MD simulations rather than a new experimental study. One MD model lacked carboxy-terminal lysines (Lys370, 372, 373, 381, 382, and 386), which may affect electrostatic conclusions.
- Evident from the text: the induced-fit/\(K_{\text{OFF}}\) conclusion is based on MD and cited in vitro/in vivo studies, and the authors note that additional transcriptional-complex partners cannot be disregarded.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
8 Valid · 5 Not valid · 25 Not checked · 34 Own results and interpretations
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“On DNA binding, the structure of p53 rigidifies, becoming more compacted.”
§ Structural Evolution and Dynamics of the p53 Proteins > STRUCTURE OF INDIVIDUAL p53 DOMAINS
What the sources say
- Disputedcites Okorokov et al. 2006 sourceExperimental — accuracy not yet measured
Our copy of Okorokov et al. (2006) never describes p53 rigidifying or compacting on DNA binding; on the contrary, the 'p53 structure in toto' and Conclusions sections argue that DNA binding is enabled by the protein's RETAINED flexibility — 'the p53 structure must re-adjust every time it encounters variously spaced sequence-specific DNA response elements... Such readjustments would be facilitated by the plasticity of the D2 organisation', with core and N/C nodes moving 'closer or further away from each other' as levers. The Conclusions state that 'the structural plasticity required for p53's activation and activity is provided by the D2 symmetry of p53 tetramer', and that binding yields a coordinated re-adjustment into a stable complex, not a rigidified/compacted form. The cryoEM map itself is of ATP-γ-S-stabilised latent p53 (low DNA-binding affinity), a hollow skewed cube (~66×82×85 Å, 220 nm³) with large ~26 Å openings, and no passage reports compaction upon DNA binding. (LLM, conf=0.65)
Checked by a reasoning model — may be wrong.
- Not checked yetcites Huang et al. 2009 source
Checked before — its earlier verdict is held back until a new check runs.
- Not checked — no full text of the sourcecites Melero et al. 2011 source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Disputed
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“In the absence of DNA, p53 forms an open cross-shaped structure with loosely coupled dimers interacting via the core domain.”
§ Structural Evolution and Dynamics of the p53 Proteins > STRUCTURE OF INDIVIDUAL p53 DOMAINS
What the sources say
- Partly supportedcites Okorokov et al. 2006 sourceExperimental — accuracy not yet measured
Our copy supports the general thrust — a DNA-free, full-length p53 tetramer that is open/hollow and built from two dimers whose association involves the core domains: the Abstract states 'The p53 molecule is a D2 tetramer, resembling a hollow skewed cube with node-like vertices of two sizes... The monomers are connected via their juxtaposed N- and C-termini within smaller N/C nodes to form dimers. The dimers form tetramers through the contacts between core nodes and N/C nodes' (Abstract; '3D structure of p53', 'The organisation of the p53 tetramer'). But two specifics attributed to this source are not in it: the shape is described as a 'hollow skewed cube of 66 × 82 × 85 Å' with large (~26 Å) openings in each facet, never as a 'cross-shaped' (cruciform) structure; and the inter-dimer link is a core-node-to-N/C-node contact mediated by three conserved loops on the face opposite the DNA-binding surface, not loosely coupled dimers interacting through the core domain, with no characterisation of the dimers as 'loosely coupled'. (LLM, conf=0.68)
- Not checked yetcites Huang et al. 2009 source
Checked before — its earlier verdict is held back until a new check runs.
- Not checked — no full text of the sourcecites Melero et al. 2011 source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“A recent report by Laptenko et al. (2015) has shown that the unmodified CTD is required in vivo for the core domain of p53 to recognize the full reper-toire of its REs, comprising those that significantly diverge from its consensus sequence.”
§ Structural Evolution and Dynamics of the p53 Proteins > STRUCTURE OF INDIVIDUAL p53 DOMAINS
What the sources say
- Supportedcites Laptenko et al. 2015 source
The Abstract states that 'dependence on the CTD correlates with the extent to which the p53 binding site deviates from the canonical consensus sequence' and that 'the CTD enables stable formation of p53-DNA complexes to divergent binding sites via DNA-induced conformational changes within the DBD itself', i.e. the core domain's recognition depends on the unmodified CTD. The in vivo (cell-based) ChIP-on-chip data (RESULTS, 'The C-terminal Domain is an Important Determinant of Site-Specific p53 DNA Binding') show WT p53 bound 355 sites while Delta30, 6KQ and 6KR bound progressively fewer (210, 172, 278) with no targets bound by the CTD variants that WT did not bind, and the SELEX section concludes 'Together the ChIP-on-chip and SELEX-based experiments reveal a role of the C-terminal domain in allowing p53 to bind to those sites that are more divergent from the consensus p53 binding sequence.' The Discussion hedges slightly ('binding of p53 to a significant number of sites within the genome might be greatly dependent on the availability of the unmodified CTD'), but the claim's 'full repertoire' framing matches the site-count data. (LLM, conf=0.88)
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Specific conformations visited by the tetramer correlate with the DNA deformation measured by the roll and twist parameters (D'Abramo et al.2015).”
§ Structural Evolution and Dynamics of the p53 Proteins > CONCLUDING REMARKS
What the sources say
- Supportedcites D'Abramo et al.2015 source
The Results section 'DNA structure and protein-coupled motions' (p. ~3) states that deviation of the roll and twist parameters from B-DNA 'is only observed in a region of the conformational space sampled during the MD simulation' and that this distortion 'coincides with a well-defined area of the tetramer essential subspace, thereby demonstrating a clear coupling between the DNA distortion and p53 core tetramer conformations'. The Discussion repeats it, separating 'static' slide deformation from 'dynamic' roll/twist deformation 'switched on and off as a function of the specific p53 tetramer conformation', as does the Abstract. The paraphrase thus matches the source, including its scope (MD simulation of the p53 core tetramer-DNA complex with C-terminal tetramerization helices). (LLM, conf=0.93)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Although all transcriptionally active forms of the mammalian p53 protein family are tetrameric (Luh et al. 2013), TAp63a in oocytes forms inactive dimers (Fig. 3B) (Deutsch et al. 2011).”
- Also stated in: § EVOLUTION OF THE p53 PROTEIN FAMILY · plain
“These dimers are stabilized by the interaction of the carboxy-terminal transactivation inhibitory (TI) domain and the amino-terminal TAD, which together block the tetramerization interface of the central tetramerization domain (Fig. 3C).”
§ Structural Evolution and Dynamics of the p53 Proteins > EVOLUTION OF THE p53 PROTEIN FAMILY
What the sources say
- Supportedcites Deutsch et al. 2011 source
The citation in the printed sentence supports the statement that TAp63α forms inactive dimers in oocytes. The Results section, “Model of the Structural Regulation of p63's Activity,” explicitly describes TAp63α in nonstressed oocytes as dimeric, closed, and inactive. The longer quoted mechanistic explanation goes beyond what that sentence attributes to Deutsch et al. (LLM, conf=0.93)
- Not checked yetcites Luh et al. 2013 source
Checked before — its earlier verdict is held back until a new check runs.
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § EVOLUTION OF THE p53 PROTEIN FAMILY · plain
40 more claims · 4 with their cited sources checked
Create a free account to see all 72 claims and to verify the 29 references still open.
- It may state two separate claims as one. 22
- Probably not a substantial claim. 5
- The quote only partly states this claim. 1
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The p53 protein is a transcription factor comprising five domains: a transactivation domain divided into two regions responsible for activating the transcription of multiple genes, a proline‐rich domain (PRD) involved in the regulation of apoptosis, a 200‐amino‐acid‐residue DNA‐binding domain (DBD), a tetramerization domain (TET) that enables the oligomerization of the p53 monomers, and a negative”
From The TP53 tumor suppressor gene: From molecular biology to clinical investigations (2025) · cites this paper as [25]
In the citing paper
“It contains an N-terminal transactivation domain (TAD, residues 1–61), a proline-rich domain (PRD, residues 64–92), a DNA-binding domain (DBD, residues 96–292) linked to a tetramerization domain (TET, residues 324–356), and a C-terminal regulatory domain (CTD, residues 364–393)260,261 (Fig. 4b).”
From Targeting p53 pathways: mechanisms, structures, and advances in therapy (2023) · cites this paper as [260]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Structural Evolution and Dynamics of the p53 Proteins > STRUCTURE AND MOLECULAR DYNAMICS OF p53
“the first in which the binding site for the ion is conserved ( purple line in Fig. 4) and the other in which it is coordinated to H175 (orange line in Fig. 4).”
§ Structural Evolution and Dynamics of the p53 Proteins > CONCLUDING REMARKS
“The p53 R175H mutant that maintains the native Zn binding (yellow line) has increased the flexibility of DBD, indicating a potential abnormal binding to the selected promoter.The p53 R175H mutant that has an alternative Zn-binding site ( purple line) has reduced flexibility of the carboxyl terminus, suggesting abnormal transactivation properties.”
Citations
Cites
p53, the cellular gatekeeper for growth and division
Levine, A. J. (1997) · Cell · doi:10.1016/s0092-8674(00)81871-1 · Cited by 7,693
Self-citationCrystal Structure of a p53 Tumor Suppressor-DNA Complex: Understanding Tumorigenic Mutations
Cho, Y., Gorina, S., Jeffrey, P. D., & Pavletich, N. P. (1994) · Science · doi:10.1126/science.8023157 · Cited by 2,551 · cited 2×
“The DBD core domain adopts an immunoglobulin-like b sandwich architecture that provides a scaffold for a DNA-binding surface, consisting of a loop–sheet–helix motif and two loops stabilized by a zinc ion (Cho et al. 1994; Joerger and Fersht 2010).”
BackgroundApplication of a Theory of Enzyme Specificity to Protein Synthesis
Koshland, D. E. (1958) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.44.2.98 · Cited by 2,396
Vousden, K. H., & Lane, D. P. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2147 · Cited by 2,272
p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development
Yang, A., Schweitzer, R., Sun, D., Kaghad, M., Walker, N., Bronson, R. T., Tabin, C., Sharpe, A., Caput, D., Crum, C., et al. (1999) · Nature · doi:10.1038/19539 · Cited by 2,225
p63 is a p53 homologue required for limb and epidermal morphogenesis
Mills, A. A., Zheng, B., Wang, X.-J., Vogel, H., Roop, D. R., & Bradley, A. (1999) · Nature · doi:10.1038/19531 · Cited by 1,988
Definition of a consensus binding site for p53
El-Deiry, W. S., Kern, S. E., Pietenpol, J. A., Kinzler, K. W., & Vogelstein, B. (1992) · Nature Genetics · doi:10.1038/ng0492-45 · Cited by 1,985
Structural basis for the binding of proline-rich peptides to SH3 domains
Yu, H., Chen, J. K., Feng, S., Dalgarno, D. C., Brauer, A. W., & Schrelber, S. L. (1994) · Cell · doi:10.1016/0092-8674(94)90367-0 · Cited by 1,001
Yang, A., Walker, N., Bronson, R., Kaghad, M., Oosterwegel, M., Bonnin, J., Vagner, C., Bonnet, H., Dikkes, P., Sharpe, A., et al. (2000) · Nature · doi:10.1038/35003607 · Cited by 990
Regulation of the specific DNA binding function of p53
Hupp, T. R., Meek, D. W., Midgley, C. A., & Lane, D. P. (1992) · Cell · doi:10.1016/0092-8674(92)90562-q · Cited by 909
Research works printed but not linked: 1
- 2015, Structural investigations of the p53/p73 homologs from the tunicate species Ciona intestinalis reveal the sequence requirements for the formation of a tetramerization domain, Protein Sci, 25, 410
Cited by
Targeting p53 pathways: mechanisms, structures, and advances in therapy
Wang, H., Guo, M., Wei, H., & Chen, Y. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01347-1 · Cited by 1,016
Towards the overcoming of anticancer drug resistance mediated by p53 mutations
Cao, X., Hou, J., An, Q., Assaraf, Y. G., & Wang, X. (2020) · Drug Resistance Updates · doi:10.1016/j.drup.2019.100671 · Cited by 172
p53 Isoforms and Their Implications in Cancer
Vieler, M., & Sanyal, S. (2018) · Cancers · doi:10.3390/cancers10090288 · Cited by 165
Evolution of cellular stress response mechanisms
Kültz, D. (2020) · Journal of Experimental Zoology Part A Ecological and Integrative Physiology · doi:10.1002/jez.2347 · Cited by 134
Emerging Roles of p53 Family Members in Glucose Metabolism
Itahana, Y., & Itahana, K. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19030776 · Cited by 126
Metadata
- Authors
- Chillemi, G., Kehrloesser, S., Bernassola, F., Desideri, A., Dötsch, V., Levine, A. J., & Melino, G.
- Affiliations
- Cineca (IT)
- Goethe University Frankfurt (DE)
- University of Rome Tor Vergata (IT)
- Institute for Advanced Study (US)
- University of Leicester (GB)
- ORCID
- Venue
- Cold Spring Harbor Perspectives in Medicine
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2016-04-18
- Volume
- 7
- Issue
- 4
- Pages
- a028308
- ISSN
- 2157-1422 (ISSN-L)
- PMC
- PMC5378015
- OpenAlex
- W2339239589
- Semantic Scholar
- 939889fb53c563be7ad87b332a0f35db24bb7c87
- Cited by
- 65
- References
- 96
- Citations by year
- 2026: 7 · 2025: 4 · 2024: 6 · 2023: 4 · 2022: 7 · 2021: 11 · 2020: 6 · 2019: 6 · 2018: 8 · 2017: 4 · 2016: 2
- Type
- posted content
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Cold Spring Harbor Perspectives in Medicine (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (publishedVersion)
- Cineca Institutional Research Information System (Tor Vergata University) (submittedVersion)
- UnitusOpen (Tuscia University) (submittedVersion)
- Funders
- Associazione Italiana per la Ricerca sul Cancro (AIRC 2014 IG15653, AIRC 5xmille MCO9979, AIRC 5xmille, 5 x mille, IG15653)
- Fondazione Roma
- Medical Research Council
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Structure and Dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heat shock proteins research
- Keywords
- p53, p73, p63, p53 family, structural evolution, molecular dynamics, C-terminal domain, DNA-binding domain, induced fit, promoter binding, cell death, cell cycle arrest, senescence, cellular stress response
- MeSH terms
- Tumor Protein p73, Binding Sites, Humans, Promoter Regions, Genetic, Transcription Factors, Trans-Activators, Tumor Suppressor Protein p53, Tumor Suppressor Proteins, Molecular Dynamics Simulation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-11-15, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-11-15 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (qwen3.8-omni-flash and gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.